Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bevacizumab (avastin) (1 trial)
Diabetic Retinopathy (Phase 3)
Dissociative Disorders (Phase 3)
Neoplasm Metastasis (Phase 3)
Retinal Detachment (Phase 3)
Retinal Diseases (Phase 3)
Trials (1 total)
Trial APIs (1 total)